Cerecor Inc. Intellectual Property Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to License Agreement, dated
License Agreements
Cerecor Inc.
2024
License Agreement by, dated November 25, 2019, by and between Flame Biosciences LLC and Eli Lilly and Company
License Agreements
Cerecor Inc.
2024
License Agreement, dated July 29, 2022, by and between Apollo AP43 Limited and Avalo Therapeutics, Inc
License Agreements
Cerecor Inc.
Pharmaceuticals
NY
2022
Exclusive Patent License Agreement, dated June 22, 2021, by and between Sanford Burnham Prebys Medical Discovery Institute and Cerecor Inc
License Agreements
Cerecor Inc.
Pharmaceuticals
CA
2021
License Agreement, dated March 25, 2021, by and between Cerecor Inc. and Kyowa Hakko Kirin Co., Ltd
License Agreements
Cerecor Inc.
Pharmaceuticals
NY
2021
Amendment No. 6 to License Agreement, dated as of November 16, 2020, by and between Medgenics Medical Israel Ltd. and The Children's Hospital of Philadelphia
License Agreements
Cerecor Inc.
Pharmaceuticals
2020
Assignment of License Agreement, dated August 8, 2019, entered into by and between Cerecor Inc., ES Therapeutics, LLC, and Armistice Capital Master Fund Ltd
License Agreements
Cerecor Inc.
Pharmaceuticals
NY
2020
License and Development Agreement, dated February 16, 2018, by and between Cerecor Inc. and Flamel Ireland Limited
License Agreements
Cerecor Inc.
Pharmaceuticals
NY
2018
CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT by and between Eli Lilly and Company and CERECOR INC. Effective Date of September 08, 2016
License Agreements
Cerecor Inc.
Pharmaceuticals
DE
2016
EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT by and between ESSEX CHEMIE AG and CERECOR INC.
License Agreements
Cerecor Inc.
Pharmaceuticals
NY
2015
EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT by and between ESSEX CHEMIE AG and CERECOR INC.
License Agreements
Cerecor Inc.
Pharmaceuticals
NY
2015